BRIDGEWATER, N.J., June 28, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.\'s (NYSE: VRX AND TSX: VRX) wholly owned subsidiary, Salix Pharmaceuticals, a leading specialty pharmaceutical company committed to the prevention and treatment of gastrointestinal disord...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]r-colonoscopies-300481172.html